Related Experiment Video
Updated: Apr 5, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Adjuvant treatment for resected colon cancer]
Abstract:
Adjuvant treatment has clearly demonstrated its efficacy and safety in resected colon cancer patients, saving thousands of lives every year worldwide. Six months adjuvant chemotherapy combining 5FU and oxaliplatin (FOLFOX or XELOX regimens) is indicated in stage III colon cancer after surgical removal of the primary tumor. The benefit of adjuvant chemotherapy seems less evident in stage II colon cancer, but this treatment should be discussed in patients with "high risk" factors for recurrence. Patient's age is also an important factor for adjuvant treatment decision. The challenge in the future will be to establish predictive and prognostic scores able to offer an even more personalized adjuvant therapeutic approach.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Treatment Resistent Cancers
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Treatment Resistant Cancers